ACRV
Acrivon Therapeutics, Inc.
2.10$
-0.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | +4,778.1% | +70.0% | -23.7% | +42.2% | -34.0% | |
| – | +5,741.1% | +31.6% | -1.8% | +40.0% | -33.7% | |
| – | +6,192.0% | -70.4% | +22.0% | +10.6% | +4.2% | |
| – | +6,192.0% | +28.3% | -0.2% | +40.8% | -33.9% | |
| – | +9,715.3% | -63.9% | – | – | – | |
| – | +1,130.4% | -91.8% | +58.8% | +16.0% | -13.1% | |
| – | +375.4% | +123.6% | +104.2% | +29.4% | -9.0% | |
| – | +1,044.8% | +9.3% | +20.8% | +20.5% | +10.9% | |
| – | +608.8% | -6.2% | +458.4% | -85.0% | +200.4% | |
| – | – | – | -28.9% | +45.9% | -36.4% | |
| – | – | – | – | – | – | |
| – | +0.0% | +69.8% | +0.7% | +73.5% | +0.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.